It's our commitment to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. The strides we've made and the culture we've created are both highly regarded and recognized.


ver the years, Bristol-Myers Squibb and its employees have received numerous distinguished awards and recognitions, including the National Medal of Technology, the Lasker Award for Medical Research and the Prix Galien Award.

Year after year, we've been hailed as being one of the best companies for working mothers, a great place to work for scientists and an acknowledged industry leader in environment, health and safety.

Below is a selection of awards and recognitions we have received.

CareerBliss Happiest Companies in America for 2018

CareerBliss Happiest Companies in America for 2018

For the second year in a row, Bristol-Myers Squibb is one of the top 10 happiest companies in America. This award recognizes the top companies from around the nation that are succeeding in building a happier culture for employees. CareerBliss analyzes thousands of reviews to create the BlissScore, which includes factors such as company culture, leadership, overall work atmosphere, and one’s relationship with coworkers.

Forbes and JUST Capital’s 100 Most JUST Companies

Forbes and JUST Capital’s 100 Most JUST Companies

We are recognized as one of the 100 Most JUST Companies in America by Forbes and JUST Capital, based on a survey of Americans on the issues they care about most.  Measures include worker pay and treatment, job creation, healthy products and communities, environmental impact and more.  Our commitment to being a good corporate citizen is at the heart of who we are, what we do and how we do it.

Military Friendly® Company

Military Friendly Company

Bristol-Myers Squibb is recognized as a Military Friendly Company by Victory Media, showcasing the most powerful and effective military programs in the workplace. The final results are determined by combining an organization’s survey scores with an assessment of the organization’s ability to meet minimum thresholds in six areas critical to success:  Military Employee Application, Hiring, Turnover, Promotion and Advancement rates and National Guard and Reserve policies.

Member of Dow Jones Sustainability Indices

Dow Jones' 2017 North American Index of Leading Sustainable Companies

We are recognized as one of Dow Jones’ 2017 North America Index of Leading Sustainable Companies. Our efforts to promote economic, social and environmental sustainability are core to our company’s mission and reflect our ongoing commitment to patients, our employees and partners, the environment and communities around the world.

2017 Working Mother Hall of Fame 100 Best Companies

2017 Working Mother 100 Best Companies

We are one of the 2017 Working Mother 100 Best Companies — marking the 20th consecutive year that our company has made the list. The company was recognized for our commitment to progressive workplace programs, including flexibility, child care and paid parental leave. 

Healthcare Businesswomen's Associations

The Healthcare Businesswomen’s Association 2017 ACE Award 

The Bristol-Myers Squibb Network of Women (B-NOW) was honored with the 2017 Large Company ACE (Advancement, Commitment, Engagement) Award by the Healthcare Businesswomen’s Association (HBA). Bristol-Myers Squibb's B-NOW global people and business resource group was recognized for impressive gender diversity metrics, strong governance structure, and strategic business and community partnerships, supported by senior executive leadership. 

Corporate Citizen 2017

100 Best Corporate Citizens 2017

For the ninth consecutive year, Bristol-Myers Squibb ranks in the top 20 of the 100 Best Corporate Citizens, a leading benchmark for socially responsible investors and other stakeholders published by Corporate Responsibility magazine. “We are proud to be recognized as a leader in Corporate Social Responsibility and sustainability, and will continue to strive to set the bar higher for ourselves, our partners and our suppliers.”

2017 Energy Star Partner of the Year

2017 ENERGY STAR® Partner of the Year

Bristol-Myers Squibb is recognized as a 2017 ENERGY STAR Partner of the Year by the U.S. Environmental Protection Agency and U.S. Department of Energy. We are engaged in comprehensive policies and programs to manage energy use at facilities worldwide.

Energy Star Challenge

ENERGY STAR Challenge for Industry

Bristol-Myers Squibb's Hopewell, New Jersey site earned the 2017 Challenge for Industry recognition. The ENERGY STAR Challenge for Industry is a national call-to-action to improve energy efficiency of America's manufacturers by 10 percent or more.  By taking the ENERGY STAR Challenge, sites set a goal to reduce their energy intensity by 10 percent within five years.  To earn this recognition, the Hopewell site upgraded and optimized its chilled water plants, retrofitted two main boilers and the HVAC systems and performed full LED lighting upgrades, among other improvements.

LGBT Award

100% score on the 2017 Corporate Equality Index (CEI)

For the 11th consecutive year, we received a perfect score of 100% on the 2017 Corporate Equality Index (CEI), a national review of workplace equality conducted annually by the Human Rights Campaign Foundation, the nation’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organization.

CEO Cancer Gold Standard

CEO Cancer Gold Standard

The CEO Roundtable on Cancer has accredited Bristol-Myers Squibb with the CEO Cancer Gold Standard™ recognizing our efforts to reduce the risk of cancer for employees and covered family members.

CEO Cancer Gold Standard

Most Admired Company in Supplier Diversity

We were recognized as a Most Admired Company in Supplier Diversity by Minority Business News as one of 101 companies that support minority business development through supplier diversity efforts to help ensure continued growth for small businesses. 

CEO Cancer Gold Standard

Pharmaceutical Executive Magazine/’s 2016 Brand of the Year

Bristol-Myers Squibb’s OPDIVO® (nivolumab) was a unanimous selection or Pharmaceutical Executive Magazine/’s 2016 Brand of the Year. Pharm Exec’s Editorial Advisory Board notes that Opdivo has “raced into the lead position in the treatment-shifting immuno-oncology space behind launches in three key cancers—melanoma, lung, and renal,” in announcing the 10th annual award in its May issue.

CEO Cancer Gold Standard

Top 30 Best-of-the-Best

We were honored as a Top 30 Best-of-the-Best company by the National Gay & Lesbian Chamber of Commerce in collaboration with its partners in the National Business Inclusion Consortium. This year’s inaugural list recognizes U.S. companies committed to diversity and inclusion across all community sectors.

CEO Cancer Gold Standard

Top 8 Pharma Companies to Work For

We are featured as one of the Top 8 Pharma Companies to Work For in a survey conducted by Biospace, a leading online community for industry news and careers. “People join Bristol-Myers Squibb because they are passionate about working for patients,” said Ann Judge, Global Head of Human Resources, Bristol-Myers Squibb. “We empower our people to pursue innovation and challenge the status quo. Our diverse global team is reflective of an inclusive culture that appreciates differences and embraces new ideas.”

CEO Cancer Gold Standard

2016 NAFE Top Companies for Executive Women

We’ve been named one of the 2016 NAFE Top Companies for Executive Women. The company was recognized for leadership initiatives, executive mentoring and sponsorship programs for female employees. Additional education and training through our seven People and Business Resource Groups, five on-site child care centers and a new network for people who choose adoption were also highlighted. 

CEO Cancer Gold Standard

America’s Best Employers for 2016

Bristol-Myers Squibb is recognized by Forbes as one of America’s Best Employers for 2016. Our employees are committed to our mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

CEO Cancer Gold Standard

“Simply the Best” Award

We were honored with the “Simply the Best” Award from the Bonnie J. Addario Lung Cancer Foundation (ALCF) for improving and advancing research for lung cancer. The award was part of ALCF’s Tenth Annual “Simply the Best“ Gala, which recognizes researchers, dedicated physicians and clinicians for their ongoing work fighting lung cancer.

CEO Cancer Gold Standard

World’s Most Admired Companies

Bristol-Myers Squibb ranks number four among the World’s Most Admired Companies in the pharmaceutical industry, according to the 2016 annual ranking published by FORTUNE magazine. Bristol-Myers Squibb ranked in the top three pharmaceutical companies for innovation, people management, quality of products and services, and use of corporate assets.

CEO Cancer Gold Standard

World’s Most Innovative Companies for 2016 / Top 10 Most Innovative Companies in Biotech

Bristol-Myers Squibb is recognized by Fast Company -- the trend-setting business innovations magazine and social platform -- as one of the World’s Most Innovative Companies for 2016 and one of the Top 10 Most Innovative Companies in Biotech.

CEO Cancer Gold Standard

2015 Collaborator Award

Bristol-Myers Squibb received the 2015 Collaborator Award from the Multiple Myeloma Research Foundation (MMRF) in recognition of the company’s commitment to collaboration and to advancing the research and development of novel therapies for patients with multiple myeloma. The Collaborator Award is part of an annual initiative by the MMRF to recognize the exceptional work of its partners from industry and academia who have played a critical role toward pursuing innovative means in the development of next-generation multiple myeloma treatments

CEO Cancer Gold Standard

2015 Society for Immunotherapy of Cancer (SITC) Collaborator Award

We’ve been honored with the 2015 Society for Immunotherapy of Cancer (SITC) Collaborator Award (Industry) for demonstrating ongoing collaboration and continued commitment toward the advancement of cancer immunotherapy. The award was part of SITC’s 30th Anniversary Awards, which were created to highlight groups and individuals who stand out as advocates for the society, and whose involvement in the organization has strengthened its position in the growing field of cancer immunotherapy.

CEO Cancer Gold Standard

2015 Top 20 R&D Employer

In October, we were recognized by Science Careers as a 2015 Top 20 R&D Employer. Our company was lauded for being an “Innovating leader in the industry” and commended for the respect afforded our employees and the loyalty they show in return. Science also noted our willingness to take risks that are backed by good science and our leading position in Immuno-Oncology. Overall, Science Careers found that Bristol-Myers Squibb is an exciting place to work.

CEO Cancer Gold Standard

Best Biotechnology Product

Bristol-Myers Squibb’s OPDIVO® (nivolumab) received the Prix Galien USA 2015 Award for Best Biotechnology Product. This represents the second award from Prix Galien USA given to Bristol-Myers Squibb’s Immuno-Oncology portfolio. YERVOY® (ipilimumab) was awarded the prestigious Prix Galien USA prize for Best Biotechnology Product in 2012.

CEO Cancer Gold Standard

50 Smartest Companies

In June, the MIT Technology Review named Bristol-Myers Squibb to its 50 Smartest Companies list for 2015. We were ranked No. 26 and recognized as a leader in Immuno-Oncology.

Glassdoor Best Places to Work

Best Places to Work across the U.S. and the U.K.

Glassdoor announced its seventh annual Employees' Choice Awards, honoring the Best Places to Work across the U.S. and the U.K. Winners were determined by the people who know these companies best -- their employees. Bristol-Myers Squibb was among the top 50 companies recognized as a best place to work.